Literature DB >> 33692782

Relevance of the Pyroptosis-Related Inflammasome Pathway in the Pathogenesis of Diabetic Kidney Disease.

Pan Liu1, Zhengdong Zhang2, Yao Li1.   

Abstract

Diabetic kidney disease (DKD) is a major cause of chronic kidney disease (CKD) in many developed and developing countries. Pyroptosis is a recently discovered form of programmed cell death (PCD). With progress in research on DKD, researchers have become increasingly interested in elucidating the role of pyroptosis in DKD pathogenesis. This review focuses on the three pathways of pyroptosis generation: the canonical inflammasome, non-canonical inflammasome, and caspase-3-mediated inflammasome pathways. The molecular and pathophysiological mechanisms of the pyroptosis-related inflammasome pathway in the development of DKD are summarized. Activation of the diabetes-mediated pyroptosis-related inflammasomes, such as nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3), Toll-like receptor 4 (TLR4), caspase-1, interleukin (IL)-1β, and the IL-18 axis, plays an essential role in DKD lesions. By inhibiting activation of the TLR4 and NLRP3 inflammasomes, the production of caspase-1, IL-1β, and IL-18 is inhibited, thereby improving the pathological changes associated with DKD. Studies using high-glucose-induced cell models, high-fat diet/streptozotocin-induced DKD animal models, and human biopsies will help determine the spatial and temporal expression of DKD inflammatory components. Recent studies have confirmed the relationship between the pyroptosis-related inflammasome pathway and kidney disease. However, these studies are relatively superficial at present, and the mechanism needs further elucidation. Linking these findings with disease activity and prognosis would provide new ideas for DKD research.
Copyright © 2021 Liu, Zhang and Li.

Entities:  

Keywords:  diabetic kidney disease; inflammasome pathway; pathogenesis; pyroptosis-related; targeted inhibition

Year:  2021        PMID: 33692782      PMCID: PMC7937695          DOI: 10.3389/fimmu.2021.603416

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  123 in total

1.  Pro-inflammatory programmed cell death.

Authors:  B T Cookson; M A Brennan
Journal:  Trends Microbiol       Date:  2001-03       Impact factor: 17.079

2.  Nephropathy in diabetes.

Authors:  Mark E Molitch; Ralph A DeFronzo; Marion J Franz; William F Keane; Carl Erik Mogensen; Hans-Henrik Parving; Michael W Steffes
Journal:  Diabetes Care       Date:  2004-01       Impact factor: 19.112

Review 3.  Targeting inflammation in diabetic kidney disease: early clinical trials.

Authors:  Maria Vanessa Perez-Gomez; Maria Dolores Sanchez-Niño; Ana Belen Sanz; Binbin Zheng; Catalina Martín-Cleary; Marta Ruiz-Ortega; Alberto Ortiz; Beatriz Fernandez-Fernandez
Journal:  Expert Opin Investig Drugs       Date:  2016-06-13       Impact factor: 6.206

Review 4.  The gasdermins, a protein family executing cell death and inflammation.

Authors:  Petr Broz; Pablo Pelegrín; Feng Shao
Journal:  Nat Rev Immunol       Date:  2019-11-05       Impact factor: 53.106

5.  ESCRT-dependent membrane repair negatively regulates pyroptosis downstream of GSDMD activation.

Authors:  Sebastian Rühl; Kateryna Shkarina; Benjamin Demarco; Rosalie Heilig; José Carlos Santos; Petr Broz
Journal:  Science       Date:  2018-11-23       Impact factor: 47.728

Review 6.  Type 2 diabetes: principles of pathogenesis and therapy.

Authors:  Michael Stumvoll; Barry J Goldstein; Timon W van Haeften
Journal:  Lancet       Date:  2005 Apr 9-15       Impact factor: 79.321

7.  Extrinsic and intrinsic apoptosis activate pannexin-1 to drive NLRP3 inflammasome assembly.

Authors:  Kaiwen W Chen; Benjamin Demarco; Rosalie Heilig; Kateryna Shkarina; Andreas Boettcher; Christopher J Farady; Pawel Pelczar; Petr Broz
Journal:  EMBO J       Date:  2019-03-22       Impact factor: 11.598

Review 8.  Roles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy.

Authors:  Yuan-Ye Qiu; Li-Qin Tang
Journal:  Pharmacol Res       Date:  2016-11-05       Impact factor: 7.658

9.  Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria.

Authors:  Edward A Miao; Irina A Leaf; Piper M Treuting; Dat P Mao; Monica Dors; Anasuya Sarkar; Sarah E Warren; Mark D Wewers; Alan Aderem
Journal:  Nat Immunol       Date:  2010-11-07       Impact factor: 25.606

10.  Clinicopathological characteristics of non-diabetic renal disease in patients with type 2 diabetes mellitus in a northeastern Chinese medical center: a retrospective analysis of 273 cases.

Authors:  Shujun Liu; Qiaoyan Guo; Hongbo Han; Peihe Cui; Xiao Liu; Lining Miao; Hongbin Zou; Guangdong Sun
Journal:  Int Urol Nephrol       Date:  2016-06-06       Impact factor: 2.370

View more
  16 in total

1.  TNFAIP3 may be key to TLR4-activation of the inflammasome in the retinal vasculature.

Authors:  Li Liu; Youde Jiang; Jena J Steinle
Journal:  Exp Eye Res       Date:  2022-05-11       Impact factor: 3.770

2.  Circ_0004951 Promotes Pyroptosis of Renal Tubular Cells via the NLRP3 Inflammasome in Diabetic Kidney Disease.

Authors:  Yulin Wang; Li Ding; Ruiqiang Wang; Yanhong Guo; ZiJun Yang; Lu Yu; LiuWei Wang; Yan Liang; Lin Tang
Journal:  Front Med (Lausanne)       Date:  2022-06-06

Review 3.  Roles and Mechanisms of Regulated Necrosis in Corneal Diseases: Progress and Perspectives.

Authors:  Wanying Lin; Minting Chen; Yacouba Cissé; Xiaofeng Chen; Lang Bai
Journal:  J Ophthalmol       Date:  2022-05-23       Impact factor: 1.974

4.  Long noncoding RNA X-inactive specific transcript regulates NLR family pyrin domain containing 3/caspase-1-mediated pyroptosis in diabetic nephropathy.

Authors:  Jia Xu; Qin Wang; Yi-Fan Song; Xiao-Hui Xu; He Zhu; Pei-Dan Chen; Ye-Ping Ren
Journal:  World J Diabetes       Date:  2022-04-15

Review 5.  Ferroptosis: A New Regulatory Mechanism in Osteoporosis.

Authors:  Pan Liu; Wenzhao Wang; Zheng Li; Yao Li; Xiaoping Yu; Ji Tu; Zhengdong Zhang
Journal:  Oxid Med Cell Longev       Date:  2022-01-17       Impact factor: 6.543

6.  The advanced glycation end-products (AGEs)/ROS/NLRP3 inflammasome axis contributes to delayed diabetic corneal wound healing and nerve regeneration.

Authors:  Luqin Wan; Xiaofei Bai; Qingjun Zhou; Chen Chen; Huifeng Wang; Ting Liu; Junfa Xue; Chao Wei; Lixin Xie
Journal:  Int J Biol Sci       Date:  2022-01-01       Impact factor: 6.580

7.  Excessive Activation of Notch Signaling in Macrophages Promote Kidney Inflammation, Fibrosis, and Necroptosis.

Authors:  Tiankui Ma; Xin Li; Yonghong Zhu; Shufan Yu; Tianyan Liu; Xiaodan Zhang; Dong Chen; Shuyan Du; Tong Chen; Shuo Chen; Yanyan Xu; Qiuling Fan
Journal:  Front Immunol       Date:  2022-02-25       Impact factor: 7.561

8.  Empagliflozin protects diabetic pancreatic tissue from damage by inhibiting the activation of the NLRP3/caspase-1/GSDMD pathway in pancreatic β cells: in vitro and in vivo studies.

Authors:  Pan Liu; Zhengdong Zhang; Jinwu Wang; Xiao Zhang; Xiaoping Yu; Yao Li
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

9.  Mechanisms of podocyte injury and implications for diabetic nephropathy.

Authors:  Federica Barutta; Stefania Bellini; Gabriella Gruden
Journal:  Clin Sci (Lond)       Date:  2022-04-14       Impact factor: 6.124

10.  Total Flavones of Abelmoschus manihot Ameliorates Podocyte Pyroptosis and Injury in High Glucose Conditions by Targeting METTL3-Dependent m6A Modification-Mediated NLRP3-Inflammasome Activation and PTEN/PI3K/Akt Signaling.

Authors:  Bu-Hui Liu; Yue Tu; Guang-Xia Ni; Jin Yan; Liang Yue; Zi-Lin Li; Jing-Jing Wu; Yu-Ting Cao; Zi-Yue Wan; Wei Sun; Yi-Gang Wan
Journal:  Front Pharmacol       Date:  2021-07-15       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.